These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 28560762

  • 1. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.
    Rovner ES, Raymond K, Andruczyk E, Juul KV.
    Low Urin Tract Symptoms; 2018 Sep; 10(3):221-230. PubMed ID: 28560762
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK, Dmochowski RR, Reddy J, van der Meulen EA.
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group development program.
    Yamaguchi O, Juul KV, Falahati A, Yoshimura T, Imura F, Kitamura M.
    Low Urin Tract Symptoms; 2020 Jan; 12(1):8-19. PubMed ID: 31397969
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP, Zinner NR, Klein BM, Nørgaard JP.
    Neurourol Urodyn; 2012 Apr; 31(4):441-7. PubMed ID: 22447415
    [Abstract] [Full Text] [Related]

  • 9. Desmopressin, as a "designer-drug," in the treatment of overactive bladder syndrome.
    Hashim H, Malmberg L, Graugaard-Jensen C, Abrams P.
    Neurourol Urodyn; 2009 Apr; 28(1):40-6. PubMed ID: 18726947
    [Abstract] [Full Text] [Related]

  • 10. Desmopressin for treating nocturia in men.
    Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P.
    Cochrane Database Syst Rev; 2017 Oct 21; 10(10):CD012059. PubMed ID: 29055129
    [Abstract] [Full Text] [Related]

  • 11. Tolterodine treatment of women with overactive bladder syndrome: Comparison of night-time and daytime dosing for nocturia.
    Tsai KH, Hsiao SM, Lin HH.
    J Obstet Gynaecol Res; 2017 Nov 21; 43(11):1719-1725. PubMed ID: 28714288
    [Abstract] [Full Text] [Related]

  • 12. Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).
    Herschorn S, Staskin D, Tu LM, Fialkov J, Walsh T, Gooch K, Schermer CR.
    Health Qual Life Outcomes; 2018 Apr 19; 16(1):69. PubMed ID: 29673355
    [Abstract] [Full Text] [Related]

  • 13. Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity.
    Lee HW, Choo MS, Lee JG, Park CH, Paick JS, Lee JZ, Han DH, Park WH, Lee KS.
    J Korean Med Sci; 2010 Dec 19; 25(12):1792-7. PubMed ID: 21165296
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A proof-of-concept study: mirabegron, a new therapy for overactive bladder.
    Chapple CR, Amarenco G, López Aramburu MA, Everaert K, Liehne J, Lucas M, Vik V, Ridder A, Snijder R, Yamaguchi O, BLOSSOM Investigator Group.
    Neurourol Urodyn; 2013 Nov 19; 32(8):1116-22. PubMed ID: 23424164
    [Abstract] [Full Text] [Related]

  • 16. Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial.
    Mitcheson HD, Samanta S, Muldowney K, Pinto CA, Rocha BA, Green S, Bennett N, Mudd PN, Frenkl TL.
    Eur Urol; 2019 Feb 19; 75(2):274-282. PubMed ID: 30661513
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
    van Kerrebroeck P, Rezapour M, Cortesse A, Thüroff J, Riis A, Nørgaard JP.
    Eur Urol; 2007 Jul 19; 52(1):221-9. PubMed ID: 17280773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.